F. Negro

The changing scenario of hepatitis D.

S. Hamid, M. Rizzetto, F. Negro, 2021, Journal of hepatology.

IL28B polymorphisms, IP‐10 and viral load predict virological response to therapy in chronic hepatitis C

G. Malerba, R. Bruno, S. Clément, 2011, Alimentary pharmacology & therapeutics.

75: A variant of IFNλ4 displaying decreased activity is associated with better hepatitis C virus clearance and reduced ISG expression

Z. Kutalik, A. Mangia, D. Semela, 2014 .

Hepatitis C virus dynamics among intravenous drug users suggest that an annual treatment uptake above 10% would eliminate the disease by 2030.

D. Semela, P. Schmid, H. Razavi, 2017, Swiss medical weekly.

Clinical Significance of the CCR5delta32 Allele in Hepatitis C

A. de Gottardi, A. Mangia, S. Clément, 2014, PloS one.

Two alleles of the human paraoxonase gene produce different amounts of mRNA. An explanation for differences in serum concentrations of paraoxonase associated with the (Leu-Met54) polymorphism.

R. James, I. Leviev, R. James, 1997, Arteriosclerosis, thrombosis, and vascular biology.